Company Overview - Knightscope, Inc. (KSCP) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended March 2025, with a consensus estimate indicating a quarterly loss of $1.47 per share, reflecting a change of +63.3% year-over-year [1][3] - Revenues are projected to be $2.68 million, which represents a 19.1% increase from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly reassessed their initial estimates [4] - The Most Accurate Estimate for Knightscope is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -11.95%, suggesting a bearish outlook from analysts [10] Historical Performance - In the last reported quarter, Knightscope was expected to post a loss of $1.88 per share but actually reported a loss of $0.78, resulting in a positive surprise of +58.51% [12] - Over the past four quarters, the company has only beaten consensus EPS estimates once [13] Industry Context - In the Zacks Technology Services industry, Bitfarms Ltd. (BITF) is expected to report a loss of $0.04 per share for the same quarter, indicating a year-over-year change of -100%, with revenues expected to be $65.47 million, up 30.1% from the previous year [17] - Bitfarms has seen a 16.7% downward revision in its consensus EPS estimate over the last 30 days, resulting in an Earnings ESP of -36.36% [18]

Company Overview - Flexible Solutions International Inc. (FSI) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.05, reflecting a +25% change, and revenues anticipated at $10.2 million, up 10.5% from the previous year [3]. Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for FSI matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - FSI currently holds a Zacks Rank of 4 (Sell), complicating the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, FSI met the consensus EPS estimate of $0.05, resulting in no surprise [12]. - Over the past four quarters, FSI has only surpassed consensus EPS estimates once [13]. Industry Comparison - In the Zacks Chemical - Specialty industry, Hawkins (HWKN) is expected to post earnings of $0.74 per share, indicating a +12.1% year-over-year change, with revenues projected at $230.08 million, up 3.2% from the previous year [17].

Core Insights - SharkNinja, Inc. reported revenue of $1.22 billion for the quarter ended March 2025, reflecting a year-over-year increase of 14.7% and a surprise of +3.99% over the Zacks Consensus Estimate of $1.18 billion [1] - The company's EPS for the quarter was $0.87, down from $1.06 in the same quarter last year, but exceeded the consensus estimate of $0.73 by +19.18% [1] Financial Performance - Net Sales in Cleaning Appliances were $441.42 million, slightly below the average estimate of $451.46 million from two analysts [4] - Net Sales in Beauty and Home Environment Appliances reached $137.89 million, surpassing the average estimate of $131.01 million [4] - Net Sales in Food Preparation Appliances amounted to $297.39 million, significantly exceeding the average estimate of $239.89 million [4] - Net Sales in Cooking and Beverage Appliances were $345.94 million, slightly above the average estimate of $344.48 million [4] Stock Performance - SharkNinja, Inc. shares have returned +3.1% over the past month, compared to the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Adient reported adjusted earnings per share (EPS) of 69 cents for Q2 fiscal 2025, an increase from 54 cents in the same period last year, exceeding the Zacks Consensus Estimate of 36 cents [1] - The company generated net sales of $3.61 billion, a 4% decrease year over year, but above the Zacks Consensus Estimate of $3.47 billion [1] Segment Performance - The Americas segment achieved revenues of $1.70 billion, up 2.3% year over year, surpassing the Zacks Consensus Estimate of $1.59 billion, with adjusted EBITDA of $94 million, an increase from $80 million in the prior-year quarter [3] - The EMEA segment reported revenues of $1.23 billion, down 10.1% year over year, but exceeding the Zacks Consensus Estimate of $1.16 billion, with adjusted EBITDA of $50 million, down from $57 million in the previous year [4] - The Asia segment's revenues were $707 million, a decline from $742 million in the same quarter last year, missing the Zacks Consensus Estimate of $736 million, with adjusted EBITDA slightly down to $110 million from $112 million [4] Financial Position - As of March 31, 2025, Adient had cash and cash equivalents of $754 million, down from $945 million as of September 30, 2024, with long-term debt at $2.39 billion [5] - Capital expenditures totaled $109 million, compared to $124 million in the prior-year quarter [5] Guidance Updates - Adient maintains its fiscal 2025 revenue guidance at $13.9 billion and adjusted EBITDA at $850 million, with equity income projected at $80 million [6] - Free cash flow is now expected to be between $150 million and $170 million, down from a previous estimate of $180 million, with capital expenditures estimated at $285 million [7]

Group 1: Earnings Performance - BlackSky Technology Inc. reported a quarterly loss of $0.42 per share, better than the Zacks Consensus Estimate of a loss of $0.47, and an improvement from a loss of $0.88 per share a year ago, representing an earnings surprise of 10.64% [1] - The company posted revenues of $29.54 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 7.27%, compared to year-ago revenues of $24.24 million [2] - Over the last four quarters, BlackSky Technology has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Group 2: Stock Performance and Outlook - BlackSky Technology shares have declined approximately 19% since the beginning of the year, while the S&P 500 has decreased by 4.3% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.39 on revenues of $30.85 million, and for the current fiscal year, it is -$1.43 on revenues of $133.35 million [7] - The estimate revisions trend for BlackSky Technology is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Group 3: Industry Context - The Technology Services industry, to which BlackSky Technology belongs, is currently in the top 27% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Nutrien reported a revenue of $5.1 billion for the quarter ended March 2025, reflecting a 5.4% decline year-over-year and a surprise of -4.18% compared to the Zacks Consensus Estimate of $5.32 billion [1] - The earnings per share (EPS) was $0.11, significantly lower than the $0.46 reported in the same quarter last year, resulting in an EPS surprise of -66.67% against the consensus estimate of $0.33 [1] Financial Performance Metrics - Nutrien's stock has returned +20.5% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change, and currently holds a Zacks Rank 3 (Hold) [3] - Potash sales volumes totaled 3,402 KTon, exceeding the five-analyst average estimate of 3,255.3 KTon [4] - Nitrogen sales volumes were reported at 2,469 KTon, slightly below the five-analyst average estimate of 2,473.23 KTon [4] - The average selling price per tonne for phosphate (industrial and feed) was $817, surpassing the five-analyst average estimate of $777.8 [4] - Total sales for Retail (Nutrient Ag Solutions) were $3.09 billion, lower than the $3.49 billion estimated by six analysts, marking a -6.6% change year-over-year [4] - Potash sales amounted to $861 million, exceeding the six-analyst average estimate of $783.90 million, but reflecting a -7.1% year-over-year change [4] - Phosphate sales were reported at $405 million, below the $435.19 million estimated by six analysts, representing an -18.8% change year-over-year [4] - Nitrogen sales reached $1.07 billion, surpassing the six-analyst average estimate of $972.08 million, with a year-over-year increase of +4.5% [4] - Net sales for Potash were $744 million, exceeding the five-analyst average estimate of $665.54 million, but showing an -8.5% year-over-year change [4] - Net sales for Nitrogen were reported at $954 million, above the $848.02 million estimated by five analysts, reflecting a +4.7% year-over-year change [4] - Retail sales for crop nutrients were $1.19 billion, significantly lower than the $1.61 billion estimated by four analysts, indicating an -8.8% year-over-year change [4]

Core Insights - Phibro Animal Health (PAHC) reported a revenue of $347.8 million for the quarter ended March 2025, marking a year-over-year increase of 32.1% and an EPS of $0.63 compared to $0.31 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $350.54 million by 0.78%, while the EPS exceeded the consensus estimate of $0.52 by 21.15% [1] Financial Performance - The company’s net sales by region showed varied performance: - United States: $209.94 million, a 31.8% increase year-over-year, but below the estimated $221.68 million [4] - Asia Pacific: $28.22 million, a significant 65.2% increase year-over-year, exceeding the estimate of $23.44 million [4] - Europe, Middle East and Africa: $38.91 million, a 17.3% increase year-over-year, below the estimate of $48.03 million [4] - Latin America and Canada: $70.75 million, a 31.9% increase year-over-year, surpassing the estimate of $55.39 million [4] Segment Performance - Animal Health segment reported net sales of $258.40 million, a 42.5% increase year-over-year, but below the estimate of $265.65 million [4] - Mineral Nutrition segment reported net sales of $66.80 million, a 4% increase year-over-year, slightly below the estimate of $66.88 million [4] - Animal Health Vaccines reported net sales of $33.40 million, a 1.5% increase year-over-year, below the estimate of $38.78 million [4] - Animal Health MFAs and other reported net sales of $181.60 million, a substantial 67.8% increase year-over-year, exceeding the estimate of $155.57 million [4] - Performance Products reported net sales of $22.70 million, a 28.5% increase year-over-year, surpassing the estimate of $18.01 million [4] EBITDA Performance - Adjusted EBITDA for the Animal Health segment was $63.10 million, above the average estimate of $60.59 million [4] - Adjusted EBITDA for the Corporate segment was -$17.30 million, better than the estimated -$19.57 million [4] Stock Performance - Phibro's shares have returned +6.5% over the past month, compared to the Zacks S&P 500 composite's +10.6% change, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]

Core Insights - Compass Minerals reported a revenue of $494.6 million for the quarter ended March 2025, marking a 35.9% increase year-over-year and exceeding the Zacks Consensus Estimate of $413.88 million by 19.50% [1] - The company's EPS was $0.63, down from $1.49 in the same quarter last year, but it surpassed the consensus EPS estimate of $0.39 by 61.54% [1] Financial Performance Metrics - Average Sales Price per ton for Plant Nutrition was $626.02, exceeding the two-analyst average estimate of $608.85 [4] - Total Salt sales volumes reached 5,105 KTon, surpassing the estimated 4,150.78 KTon [4] - Average Sales Price per ton for Total Salt was $84.76, slightly below the estimated $87.42 [4] - Plant Nutrition sales volumes were 93 KTon, exceeding the average estimate of 76 KTon [4] - Sales to external customers for Salt were $432.70 million, up 39.4% year-over-year and above the estimated $362.42 million [4] - Sales to external customers for Plant Nutrition were $58.30 million, representing a 16.4% year-over-year increase and exceeding the estimate of $46.26 million [4] - Operating earnings for Plant Nutrition were -$1.80 million, better than the estimated -$3.66 million [4] - Operating earnings for Salt were $66.90 million, above the average estimate of $63.52 million [4] Stock Performance - Compass shares have returned +48.7% over the past month, significantly outperforming the Zacks S&P 500 composite's +10.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Groupon reported revenue of $117.19 million for the quarter ended March 2025, reflecting a year-over-year decline of 4.8% but exceeding the Zacks Consensus Estimate by 1.46% [1] - The company's EPS was $0.18, a significant increase from $0.06 in the same quarter last year, resulting in an EPS surprise of 190.00% compared to the consensus estimate of -$0.20 [1] Revenue Performance - North America revenue was $91.11 million, surpassing the average estimate of $89.33 million, but down 3.2% year-over-year [4] - International revenue totaled $26.07 million, below the average estimate of $26.91 million, marking a 9.9% decline year-over-year [4] - Local revenue in North America was $85.94 million, exceeding the estimate of $83.23 million, but down 0.6% from the previous year [4] - International goods revenue was $2.26 million, above the estimate of $1.97 million, yet down 7.4% year-over-year [4] - North America goods revenue plummeted to $1.51 million, significantly below the estimate of $2.24 million, representing a drastic 50.9% decline year-over-year [4] - International local revenue was $22.42 million, slightly below the estimate of $22.54 million, reflecting a 9.4% decrease year-over-year [4] - International travel revenue was $1.39 million, falling short of the estimate of $2.41 million, with a year-over-year decline of 20.7% [4] - North America travel revenue was $3.66 million, below the estimate of $3.87 million, indicating a 20.4% decrease year-over-year [4] Stock Performance - Groupon's shares have returned +0.7% over the past month, in contrast to the Zacks S&P 500 composite's +10.6% change, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3]

分组1 - The ONE Group Hospitality, Inc. reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of a loss of $0.17 per share, compared to a loss of $0.02 per share a year ago, representing an earnings surprise of 182.35% [1] - The company posted revenues of $211.13 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.17%, and this is a significant increase from year-ago revenues of $85 million [2] - The stock has increased approximately 5.5% since the beginning of the year, while the S&P 500 has declined by 4.7% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $210.87 million, and for the current fiscal year, it is -$0.65 on revenues of $844.77 million [7] - The Zacks Industry Rank for Retail - Restaurants is currently in the bottom 20% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8]